Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Past President Lecture Series

MDS Presidential Perspective: Musings on Disease Modification for Parkinson's Disease - Presented by Dr. Anthony Lang

Length:45 MinutesCME Credits:1Release Date:Dec 02, 2020

Experienced / IntermediateExpert / AdvancedPast President Lecture Series

Program Description

The MDS Presidential Perspective: Musings on Disease Modification for Parkinson's Disease - Presented by Dr. Anthony Lang webinar will summarize the reasons for believing that "one drug will not fit all" for disease modification in Parkinson's disease and will highlight the related hypothesis that initial involvement of the substantia nigra (e.g., Braak Stage 3) may trigger an accelerated process driven by factors unique to dopaminergic neurons independent of the status of alpha synuclein aggregation.

Faculty

Anthony Lang, OC, MD, FRCPC

Course Purpose

The primary purpose of this webinar is to provide information on disease modification in Parkinson's disease.

Learning Objectives

Upon completion of this activity learners will be able to:
1. Understand the various types of heterogeneity of Parkinson’s disease
2. Recognize the need to consider combinations of disease modifying therapies (i.e. cocktails)
3. Consider the possibility that the initial involvement of dopaminergic neurons in PD may trigger an accelerated process that may proceed independent of ongoing spread and toxicity of alpha synuclein

Intended Audience

This activity is intended for clinical and basic neuroscientists interested in disease modification in Parkinson’s disease.

Accreditation Credit

The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Method of Participation

The course must be attended in their entirety. Partial credit is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

Faculty Disclosure

PRESWEB7-Discl

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Hardware and Software Requirements

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.

Contact Us

Stephanie Jensen

Disclaimer

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice